{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:22Z","timestamp":1792025182124,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"52","license":[{"start":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T00:00:00Z","timestamp":1217808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T00:00:00Z","timestamp":1217808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2008,11,6]]},"DOI":"10.1038\/onc.2008.258","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T06:09:30Z","timestamp":1218521370000},"page":"6623-6634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":181,"title":["C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells"],"prefix":"10.1038","volume":"27","author":[{"given":"D","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mannava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Grachtchouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-H","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Wawrzyniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A E","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T J","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E V","family":"Prochownik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Soengas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Nikiforov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,4]]},"reference":[{"key":"BFonc2008258_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.semcancer.2006.07.012","volume":"16","author":"C Arvanitis","year":"2006","unstructured":"Arvanitis C, Felsher DW . (2006). Conditional transgenic models define how MYC initiates and maintains tumorigenesis. Semin Cancer Biol 16: 313\u2013317.","journal-title":"Semin Cancer Biol"},{"key":"BFonc2008258_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.jid.5700490","volume":"127","author":"J Bauer","year":"2007","unstructured":"Bauer J, Curtin JA, Pinkel D, Bastian BC . (2007). Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol 127: 179\u2013182.","journal-title":"J Invest Dermatol"},{"key":"BFonc2008258_CR3","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1128\/MCB.24.7.2842-2852.2004","volume":"24","author":"JA Benanti","year":"2004","unstructured":"Benanti JA, Galloway DA . (2004). Normal human fibroblasts are resistant to RAS-induced senescence. Mol Cell Biol 24: 2842\u20132852.","journal-title":"Mol Cell Biol"},{"key":"BFonc2008258_CR4","doi-asserted-by":"publisher","first-page":"35693","DOI":"10.1074\/jbc.M304597200","volume":"278","author":"A Biroccio","year":"2003","unstructured":"Biroccio A, Amodei S, Antonelli A, Benassi B, Zupi G . (2003). Inhibition of c-Myc oncoprotein limits the growth of human melanoma cells by inducing cellular crisis. J Biol Chem 278: 35693\u201335701.","journal-title":"J Biol Chem"},{"key":"BFonc2008258_CR5","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1128\/MCB.25.15.6464-6474.2005","volume":"25","author":"JS Boehm","year":"2005","unstructured":"Boehm JS, Hession MT, Bulmer SE, Hahn WC . (2005). Transformation of human and murine fibroblasts without viral oncoproteins. Mol Cell Biol 25: 6464\u20136474.","journal-title":"Mol Cell Biol"},{"key":"BFonc2008258_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0531-5565(00)00083-8","volume":"35","author":"F Bringold","year":"2000","unstructured":"Bringold F, Serrano M . (2000). Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 35: 317\u2013329.","journal-title":"Exp Gerontol"},{"key":"BFonc2008258_CR7","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1101\/gad.1437206","volume":"20","author":"L Chin","year":"2006","unstructured":"Chin L, Garraway LA, Fisher DE . (2006). Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 20: 2149\u20132182.","journal-title":"Genes Dev"},{"key":"BFonc2008258_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrc1884","volume":"6","author":"M Collado","year":"2006","unstructured":"Collado M, Serrano M . (2006). The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 6: 472\u2013476.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2008258_CR9","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H et al. (2005). Distinct sets of genetic alterations in melanoma. N Engl J Med 353: 2135\u20132147.","journal-title":"N Engl J Med"},{"key":"BFonc2008258_CR10","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/ncb1471","volume":"8","author":"C Denoyelle","year":"2006","unstructured":"Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR et al. (2006). Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 8: 1053\u20131063.","journal-title":"Nat Cell Biol"},{"key":"BFonc2008258_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1535-6108(03)00242-3","volume":"4","author":"S Drayton","year":"2003","unstructured":"Drayton S, Rowe J, Jones R, Vatcheva R, Cuthbert-Heavens D, Marshall J et al. (2003). Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell 4: 301\u2013310.","journal-title":"Cancer Cell"},{"key":"BFonc2008258_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS el-Deiry","year":"1993","unstructured":"el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817\u2013825.","journal-title":"Cell"},{"key":"BFonc2008258_CR13","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1158\/0008-5472.CAN-03-4030","volume":"65","author":"J Gil","year":"2005","unstructured":"Gil J, Kerai P, Lleonart M, Bernard D, Cigudosa JC, Peters G et al. (2005). Immortalization of primary human prostate epithelial cells by c-Myc. Cancer Res 65: 2179\u20132185.","journal-title":"Cancer Res"},{"key":"BFonc2008258_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrm1987","volume":"7","author":"J Gil","year":"2006","unstructured":"Gil J, Peters G . (2006). Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7: 667\u2013677.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2008258_CR15","first-page":"176","volume":"10","author":"CR Goding","year":"2000","unstructured":"Goding CR . (2000). Melanocyte development and malignant melanoma. Forum (Genova) 10: 176\u2013187.","journal-title":"Forum (Genova)"},{"key":"BFonc2008258_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.seminoncol.2006.04.002","volume":"33","author":"JA Gollob","year":"2006","unstructured":"Gollob JA, Wilhelm S, Carter C, Kelley SL . (2006). Role of Raf kinase in cancer: therapeutic potential of targeting the Raf\/MEK\/ERK signal transduction pathway. Semin Oncol 33: 392\u2013406.","journal-title":"Semin Oncol"},{"key":"BFonc2008258_CR17","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1101\/gad.1100303","volume":"17","author":"C Grandori","year":"2003","unstructured":"Grandori C, Wu KJ, Fernandez P, Ngouenet C, Grim J, Clurman BE et al. (2003). Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev 17: 1569\u20131574.","journal-title":"Genes Dev"},{"key":"BFonc2008258_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature05661","volume":"445","author":"V Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer V, Wellbrock C, Marais R . (2007). Melanoma biology and new targeted therapy. Nature 445: 851\u2013857.","journal-title":"Nature"},{"key":"BFonc2008258_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/1097-0142(20000701)89:1<97::AID-CNCR14>3.0.CO;2-0","volume":"89","author":"KM Greulich","year":"2000","unstructured":"Greulich KM, Utikal J, Peter RU, Kr\u00e4hn G . (2000). c-MYC and nodular malignant melanoma. A case report. Cancer 89: 97\u2013103.","journal-title":"Cancer"},{"key":"BFonc2008258_CR20","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1073\/pnas.0600069103","volume":"103","author":"I Guney","year":"2006","unstructured":"Guney I, Wu S, Sedivy JM . (2006). Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). Proc Natl Acad Sci USA 103: 3645\u20133650.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2008258_CR21","doi-asserted-by":"publisher","first-page":"10968","DOI":"10.1073\/pnas.0611638104","volume":"104","author":"L Ha","year":"2007","unstructured":"Ha L, Ichikawa T, Anver M, Dickins R, Lowe S, Sharpless NE et al. (2007). ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc Natl Acad Sci USA 104: 10968\u201310973.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2008258_CR22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1053\/j.seminoncol.2007.09.011","volume":"34","author":"F Haluska","year":"2007","unstructured":"Haluska F, Pemberton T, Ibrahim N, Kalinsky K . (2007). The RTK\/RAS\/BRAF\/PI3K pathways in melanoma: biology, small molecule inhibitors, and potential applications. Semin Oncol 34: 546\u2013554.","journal-title":"Semin Oncol"},{"key":"BFonc2008258_CR23","doi-asserted-by":"publisher","first-page":"2301s","DOI":"10.1158\/1078-0432.CCR-05-2518","volume":"12","author":"FG Haluska","year":"2006","unstructured":"Haluska FG, Tsao H, Wu H, Haluska FS, Lazar A, Goel V . (2006). Genetic alterations in signaling pathways in melanoma. Clin Cancer Res 12: 2301s\u20132307s.","journal-title":"Clin Cancer Res"},{"key":"BFonc2008258_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-59745-361-5_3","volume":"371","author":"K Itahana","year":"2007","unstructured":"Itahana K, Campisi J, Dimri GP . (2007). Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 371: 21\u201331.","journal-title":"Methods Mol Biol"},{"key":"BFonc2008258_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cell.2007.02.022","volume":"128","author":"MB Kastan","year":"2007","unstructured":"Kastan MB . (2007). Wild-type p53: tumors can't stand it. Cell 128: 837\u2013840.","journal-title":"Cell"},{"key":"BFonc2008258_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10495-005-3088-0","volume":"11","author":"R Kim","year":"2006","unstructured":"Kim R, Emi M, Tanabe K, Murakami S . (2006). Role of the unfolded protein response in cell death. Apoptosis 11: 5\u201313.","journal-title":"Apoptosis"},{"key":"BFonc2008258_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1054\/bjoc.2000.1535","volume":"84","author":"GM Kraehn","year":"2001","unstructured":"Kraehn GM, Utikal J, Udart M, Greulich KM, Bezold G, Kaskel P et al. (2001). Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases. Br J Cancer 84: 72\u201379.","journal-title":"Br J Cancer"},{"key":"BFonc2008258_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","volume":"74","author":"SW Lowe","year":"1993","unstructured":"Lowe SW, Ruley HE, Jacks T, Housman DE . (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957\u2013967.","journal-title":"Cell"},{"key":"BFonc2008258_CR29","first-page":"61","volume":"1602","author":"W Lutz","year":"2002","unstructured":"Lutz W, Leon J, Eilers M . (2002). Contributions of Myc to tumorigenesis. Biochim Biophys Acta 1602: 61\u201371.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2008258_CR30","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/jnci\/djg123","volume":"95","author":"JL Maldonado","year":"2003","unstructured":"Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T et al. (2003). Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95: 1878\u20131890.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2008258_CR31","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.2741\/1755","volume":"10","author":"F Meier","year":"2005","unstructured":"Meier F, Schittek B, Busch S, Garbe C, Smalley K, Satyamoorthy K et al. (2005). The RAS\/RAF\/MEK\/ERK and PI3K\/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front Biosci 10: 2986\u20133001.","journal-title":"Front Biosci"},{"key":"BFonc2008258_CR32","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature03890","volume":"436","author":"C Michaloglou","year":"2005","unstructured":"Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM et al. (2005). BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720\u2013724.","journal-title":"Nature"},{"key":"BFonc2008258_CR33","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1056\/NEJMra062285","volume":"355","author":"WJ Mooi","year":"2006","unstructured":"Mooi WJ, Peeper DS . (2006). Oncogene-induced cell senescence\u2014halting on the road to cancer. N Engl J Med 355: 1037\u20131046.","journal-title":"N Engl J Med"},{"key":"BFonc2008258_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0092-8674(03)00401-X","volume":"113","author":"M Narita","year":"2003","unstructured":"Narita M, N\u0169nez S, Heard E, Narita M, Lin AW, Hearn SA et al. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703\u2013716.","journal-title":"Cell"},{"key":"BFonc2008258_CR35","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1038\/sj.onc.1202746","volume":"18","author":"CE Nesbit","year":"1999","unstructured":"Nesbit CE, Tersak JM, Prochownik EV . (1999). MYC oncogenes and human neoplastic disease. Oncogene 18: 3004\u20133016.","journal-title":"Oncogene"},{"key":"BFonc2008258_CR36","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1128\/MCB.22.14.5054-5063.2002","volume":"22","author":"MA Nikiforov","year":"2002","unstructured":"Nikiforov MA, Chandriani S, Park J, Kotenko I, Matheos D, Johnsson A et al. (2002). TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Mol Cell Biol 22: 5054\u20135063.","journal-title":"Mol Cell Biol"},{"key":"BFonc2008258_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng1054","volume":"33","author":"PM Pollock","year":"2003","unstructured":"Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM et al. (2003). High frequency of BRAF mutations in nevi. Nat Genet 33: 19\u201320.","journal-title":"Nat Genet"},{"key":"BFonc2008258_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1365-2168.1998.00528.x","volume":"85","author":"DA Ross","year":"1998","unstructured":"Ross DA, Wilson GD . (1998). Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma. Br J Surg 85: 46\u201351.","journal-title":"Br J Surg"},{"key":"BFonc2008258_CR39","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-04-2423","volume":"65","author":"A Sharma","year":"2005","unstructured":"Sharma A, Trivedi NR, Zimmerman MA, Tuveson DA, Smith CD, Robertson GP . (2005). Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Cancer Res 65: 2412\u20132421.","journal-title":"Cancer Res"},{"key":"BFonc2008258_CR40","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1038\/sj.onc.1206461","volume":"22","author":"E Sharpless","year":"2003","unstructured":"Sharpless E, Chin L . (2003). The INK4a\/ARF locus and melanoma. Oncogene 22: 3092\u20133098.","journal-title":"Oncogene"},{"key":"BFonc2008258_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35051606","volume":"409","author":"MS Soengas","year":"2001","unstructured":"Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X et al. (2001). Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409: 207\u2013211.","journal-title":"Nature"},{"key":"BFonc2008258_CR42","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1038\/sj.onc.1207923","volume":"23","author":"M Takaoka","year":"2004","unstructured":"Takaoka M, Harada H, Deramaudt TB, Oyama K, Andl CD, Johnstone CN et al. (2004). Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction. Oncogene 23: 6760\u20136768.","journal-title":"Oncogene"},{"key":"BFonc2008258_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/35003506","volume":"404","author":"H Tanaka","year":"2004","unstructured":"Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K et al. (2004). A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404: 42\u201349.","journal-title":"Nature"},{"key":"BFonc2008258_CR44","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05541","volume":"445","author":"A Ventura","year":"2007","unstructured":"Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L et al. (2007). Restoration of p53 function leads to tumour regression in vivo. Nature 445: 661\u2013665.","journal-title":"Nature"},{"key":"BFonc2008258_CR45","doi-asserted-by":"publisher","first-page":"11348","DOI":"10.1158\/0008-5472.CAN-06-1748","volume":"66","author":"M Verhaegen","year":"2006","unstructured":"Verhaegen M, Bauer JA, Martin de la Vega C, Wang G, Wolter KG, Brenner JC et al. (2006). A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. Cancer Res 66: 11348\u201311359.","journal-title":"Cancer Res"},{"key":"BFonc2008258_CR46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.semcancer.2006.07.015","volume":"16","author":"M Vita","year":"2006","unstructured":"Vita M, Henriksson M . (2006). The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 16: 318\u2013330.","journal-title":"Semin Cancer Biol"},{"key":"BFonc2008258_CR47","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/sj.onc.1210823","volume":"27","author":"H Wang","year":"2008","unstructured":"Wang H, Mannava S, Grachtchouk V, Zhuang D, Soengas MS, Gudkov AV et al. (2008). c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene 27: 1905\u20131915.","journal-title":"Oncogene"},{"key":"BFonc2008258_CR48","doi-asserted-by":"publisher","first-page":"13028","DOI":"10.1073\/pnas.0701953104","volume":"104","author":"CH Wu","year":"2007","unstructured":"Wu CH, van Riggelen J, Yetil A, Fan AC, Bachireddy P, Felsher DW . (2007). Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc Natl Acad Sci USA 104: 13028\u201313033.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2008258_CR49","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V et al. (2007). Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656\u2013660.","journal-title":"Nature"},{"key":"BFonc2008258_CR50","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/cr.2007.64","volume":"17","author":"Q Yang","year":"2007","unstructured":"Yang Q, Guan KL . (2007). Expanding mTOR signaling. Cell Res 17: 666\u2013681.","journal-title":"Cell Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2008258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2008258","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2008258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:09:28Z","timestamp":1647878968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2008258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,4]]},"references-count":50,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2008,11,6]]}},"alternative-id":["BFonc2008258"],"URL":"https:\/\/doi.org\/10.1038\/onc.2008.258","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,4]]},"assertion":[{"value":"6 March 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}